Effects of diabetes drug counseling by the pharmacist, diabetic disease booklet and special medication containers on glycaemic control of type 2 diabetes mellitus: a randomized controlled trial

Author(s): Suppapitiporn S, Chindavijak B, Onsanit S


Background: type 2 diabetes mellitus continues to increase in prevalence worldwide. Many factors have been cited as contributing to compliance, such as family and social support, education, number of tablets per dose, frequency of administration and health care provider communication. Toward these goals, the present study was developed to measure the effect offactors on glycemic control such as diabetes education by pharmacists, a diabetes disease booklet and special medication containers.

Material and method: A total of 360 volunteers with type 2 DM patients were recruited, participants were simple randomized to control 180 and intervention 180 patients. Which intervention categorized to 4 groups; all intervention groups received diabetes drug counseling by a pharmacist, one group received plus a diabetes booklet, one received plus special medical containers and the last group received all of them. The interventions were done at the 1st time of visit. Both the control and intervention groups were monitored for fasting plasma glucose and HbA1c at 0, 3, 6 months and glycemic level in both groups was compared.

Results: After 3 months, mean fasting plasma glucose and HbA1c decreased wiih the intervention group vs. control group (152.36 +/- 39.73 to 131.52 +/- 35.22 mg%) and (150.16 +/- 41.78 to 153.98 +/- 47.95 mg%) respectively; (p < 0.001). HbA1c level 8.16 +/- 1.44 to 7.72 +/- 1.26 vs 8.01 +/- 1.51 to 8.38 +/- 1.46 respectively; (p < 0.001). After 6 months, mean fasting plasma glucose and HbA1c decreased with the intervention group vs. control group (152.36 +/- 39.73 to 145.20 +/- 46.07 mg%) and (150.16 +/- 41.78 to 159.16 +/- 54.90 mg%) respectively; (p < 0.013). HbA1c level 8.16 +/- 1.44 to 7.91 +/- 1.27 vs. 8.01 +/- 1.51 to 8.80 +/- 1.36 respectively; (p < 0.001). The most favorable glycemic outcome was the group that received all of the interventions; mean FPG was reduced from 147.46 +/- 36.07 to 125.38 +/- 31.12 mg% (p < 0.000) in 1nd visit (3 months later) and still reducing effect on the 2nd visit (6 month later) mean FPG from 147.46 +/- 36.07 to 130.21 +/- 33.96 mg% (p < 0.016) also the same way in HbA 1c level. The group that received only drug counseling by pharmacist had no significant reduction in FPG and HbA1c. (p > 0.05).

Conclusion: Drug counseling by a pharmacist has little beneficial effect on diabetes management outcome compared to the diabetes booklet and special drug container. To improve glycemic control of type 2 DM is to integrate self-management in daily life, wide a variety of education, drug taken behavior and health care provider available communication produce improvement in patient management and is somewhat better when used in combination.

Similar Articles

National standards for diabetes self-management education

Author(s): Mensing C, Boucher J, Cypress M, Weinger K, Mulcaby K, et al.

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

Author(s): Parving HH, Lehnert H, Bröchner-Mortensen J, Gomis R, Andersen S, et al.

Am Fam Phys 55: 817-824

Author(s): Baliga BS, Fonseca VA (l997) Recent advances in the treatment of type II diabetes mellitus


Author(s): Bailey CJ, Turner RC

Incidence of lactic acidosis in metformin users

Author(s): Stang M, Wysowski DK, Butler-Jones D

Profiles of people with type 2 diabetes mellitus

Author(s): Savoca MR, Miller CK, Quandt SA

Phenformin-induced lactic acidosis precipitated by tetracycline

Author(s): Arc A, Korhonen T, Halinen M

Br J Clin Pharmacol 23: 545-55 1

Author(s): Somogyi A, Stockley C, Keal J, Rolan P, Bockner F (1 987) Reduction of metformin renal tubular secretion by cimetidine in man

Oral hypoglycemic agents in type II diabetes mellitus

Author(s): Lubbos H, Miller JL, Rose LI

Primary care diabetes

Author(s): Yeap BB

Ann Pharmacother 30: 20-26

Author(s): Kubacka RT, Antal EJ, Juhi RP, Weishman IR (1 996) Effects of aspirin and ibuprofen on the pharmacokinetics and pharmacodynamics of glyburide in healthy subjects

Suiphaphenazole-induced hypoglycaemic attacks in tolbutamide-treated diabetics

Author(s): Christensen LK, Hansen J, Kristensen M

Drug-induced hypoglycemic coma in 102 diabetic patients

Author(s): Ben-Ami H, Nagachandran P, Mendelson A, Edoute Y

Attitudes and beliefs about exercise among persons with non-insulin dependent diabetes

Author(s): Swift CS, Armstrong JE, Berman KA, Cambell RK, Pond-Smith D

Nursing Research: Principle and Methods (7thedn)

Author(s): Polit DF, Hungler BP

The role of self monitoring of blood glucose in the care of people with diabetes: report of global consensus conference

Author(s): Bergenstal RM, Gavin JR, Global Consensus conference on Glucose monitoring panel

Self-monitoring of blood glucose among diabetes patients attending government health clinics

Author(s): Mastura I, Mimi O, Piterman L, Teng CL, Wijesinha S

Ethnicity and glycaemic control are major determinants of diabetic dyslipidaemia in Malaysia

Author(s): Ismail IS, Nazaimoon W, Mohamad W, Letchuman R, Hew FL, et al.

Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes

Author(s): Pahor M, Psaty BM, Alderman MH, Applegate WB, Williamson JD, et al.

Using intake biomarkers to evaluate the extent of dietary misreporting in a large sample of adults: the OPEN study

Author(s): Subar AF, Kipnis V, Troiano RP, Midthune D, Schoeller DA, et al.

Nutrition recommendations and interventions for diabetes--2006: a position statement of the American Diabetes Association

Author(s): Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG, et al.

The Dietician challenge: the implementation of nutritional advice for people with diabetes

Author(s): Nutrition sub-committee of the diabetes Care Advisory Committee of Diabetes UK

The epidemic of obesity

Author(s): Stein CJ, Colditz GA

Clinic based support to help overweight patients with type 2 diabetes increase physical activity and loss weight

Author(s): Christian JG, Bessesen DH, Byers TE, Christian KK, Goldstein MG, et al.

Self-help weight loss versus a structured commercial program after 26 week: a randomized controlled study

Author(s): Heshka S, Greenway F, Anderson JW, Atkinson RL, Hill JO, et al.

Patient education in the management of diabetes mellitus

Author(s): Tan SL, Yong LS, Wan S, Wong ML

Structured patient education: the diabetes X-PERT programme makes a difference

Author(s): Deakin T, Cade J, Williams R, Greenwood D

A taxanomy of diabetes educational intervention

Author(s): Elasy T, Ellis S, Brown A, Pichert J

Patient adherence improves glycaemic control

Author(s): Rhee MK, Slocum W, Ziemer DC, Culler SD, Cook CB, et al.

The pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia

Author(s): Krass I, Armour CL, Mitchell B, Brilliant M, Dienaar R, et al.

Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin

Author(s): Welschen LM, Bloemendal E, Nijpels G, Dekker J, Heine RJ, et al.

Access to transportation and health care utilization in a rural region

Author(s): Arcury TA, Preisser JS, Gesler WM, Powers JM

Driving distance as a barrier to glycaemic control in diabetes

Author(s): Strauss K, MacLean C, Troy A, Littenberg B

The use of text messaging to improve attendance in primary care: a randomized controlled trial

Author(s): Leong KC, Chen WS, Leong KW, Mastura I, Mimi O, et al.